Brief: Immutep Receives Constructive Regulatory Feedback On TACTI-004 Registrational Trial In Metastatic Non-Small Cell Lung Cancer
21/12/2023 13:21
Dec 21 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP RECEIVES CONSTRUCTIVE REGULATORY FEEDBACK ON
TACTI-004
REGISTRATIONAL TRIAL IN METASTATIC NON-SMALL CELL LUNG CANCER
* IMMUTEP LTD - PLANS TO ANNOUNCE ITS FINAL TRIAL DESIGN FOR
TACTI-004 IN Q1 OF CY2024
Source text for Eikon: ID:nGNX230ymm
Further company coverage: IMM.AX